Dr. Bazhenova on Sequential Use of Immunotherapy and EGFR TKIs in Lung Cancer
June 11th 2019
Lyudmila A. Bazhenova, MD, medical oncologist, professor of clinical medicine, University of California, San Diego, discusses research that has looked at the use of EGFR TKIs after immunotherapy in patients with EGFR-mutant non–small cell lung cancer.